Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US

Introduction: This study evaluated the cost-effectiveness of atezolizumab + chemotherapy vs. chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC) in the United States (US).Methods: The three health states partitioned survival (PS) model was used over the lifetime. E...

詳細記述

保存先:
書誌詳細
主要な著者: Yingcheng Wang (著者), Mingjun Rui (著者), Lan Yang (著者), Xintian Wang (著者), Ye Shang (著者), Aixia Ma (著者), Hongchao Li (著者)
フォーマット: 図書
出版事項: Frontiers Media S.A., 2021-04-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可